A New Abuse-Deterrent Opioid - Xtampza ER
The FDA has approved Xtampza ER (Collegium), a new extended-release, abuse-deterrent capsule formulation of oxycodone, for management of pain severe enough to require daily,...
Spritam - A New Formulation of Levetiracetam for Epilepsy
The FDA has approved[r]